Capitalizing on its focus on the intelligence communities, data analytics, and artificial intelligence software provider ...

AI is a new tool to help investors analyze data, but can it beat the stock market? Here's how a chatbot's stock picks fared ...

Discussing how the market initially reacted, Cramer explained that when the panel of federal judges declared the majority of ...

You can find investment watches through a variety of channels. "For brand-new watches, authorized dealers are the safest ...

Have you ever read a headline that made you want to throw your phone across the room? Not out of anger, but frustration for your own bad investing decisions? You know the headlines I mean. “NVIDIA up ...

To top it off, in conjunction with its Q1 report, Palantir's management team gave guidance for a strong Q2 -- it expects ...

What are the best tech-focused ETFs for investors right now? Seeking Alpha analysts offer their picks. Read more here.

President Trump's "Liberation Day" tariffs rocked Wall Street in April, prompting many top analysts to slash their 2025 ...

Salesforce lags despite solid profits, but AI traction, M&A moves, and low valuation offer upside. See why CRM stock is ...

Regeneron Pharmaceuticals (NasdaqGS:REGN) announced favorable Phase 3 trial results for itepekimab and entered a significant licensing agreement with Telesis Bio, enhancing its R&D capabilities.